Skip to main content

Table 5 The CD4, CD8, CD68 and CD163 expression in 26 PD-L1-positive lymphocytes cases

From: The immune checkpoint regulator PD-L1 expression are associated with clinical progression in prostate cancer

 

Negative

Positive

P

CD4

4

22

0.308

CD8

7

19

 

CD68

8

18

0.388

CD163

11

15

Â